Company intelligence / Profile preview

Siloam Vision

Oswego or Portland area*, Oregon, United Statessiloamvision.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Siloam Vision has developed a suite of advanced imaging devices and AI-enabled software platforms to improve the diagnosis and management of retinopathy of prematurity. Their proprietary systems have received multiple FDA Breakthrough Device Designations. Clinical validation is ongoing with strong results in sensitivity/specificity targets, aiming to reduce preventable childhood blindness globally

Therapeutic areas: Ophthalmology
Modalities: DeviceArtificial Intelligence (AI)-enabled diagnosticsImaging system
Industry: Medical Imaging

Partnerships

Orbis InternationalOregon Health & Science UniversityForus Health

Beyond the preview

Go deeper on Siloam Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siloam Vision.

Explore the full profile